40 Year Trends in Postmenopausal Hormone Therapy and the Incidence of Breast Cancer

40 Year Trends in Postmenopausal Hormone Therapy and the Incidence of Breast Cancer Disparities Exist Between Black and White Women The Women’s Health Initiative (WHI) initiated 2 randomized trials in 1993. The trials included conjugated equine estrogen (CEE) in postmenopausal women with a prior hysterectomy and CEE plus medroxyprogesterone acetate (MPA) in those with intact…

Read More

Dr. DellaCroce on Mastectomy and Why Details Matter

Dr. DellaCroce on Mastectomy and Why Details Matter Dr. DellaCroce, a founding surgeon of the Center for Restorative Breast Surgery and St. Charles Surgical Hospital, introduces his “Mastectomy Rule of 3’s” and explains what you should know about mastectomy before making decisions. You’ll learn how those important early decisions in your breast cancer journey impact…

Read More

Risk of a Second Breast Cancer Following Bilateral Mastectomy

Risk of a Second Breast Cancer Following Bilateral Mastectomy There is little doubt that bilateral mastectomy (BM) for unilateral cancer has risen sharply in the US, even in patients not carrying a deleterious mutation. This occurred despite data suggesting no difference in survival between BM, unilateral mastectomy (UM) and breast-conserving therapy (BCT). It appears therefore…

Read More